- Johnson & Johnson's JNJ CEO Alex Gorsky will step away from his role in January 2022 in favor of Joaquin Duato, the vice-chairman of the executive committee.
- He served as CEO for nine years and will become J&J's executive chairman effective January 3.
- Gorsky joined up with Janssen back in 1988 as a sales representative before climbing his way up the ladder at J&J before eventually being named CEO in 2012.
- In an interview with the Wall Street Journal, Gorsky said he was making the move due to "health issues."
- During his run atop J&J, Gorsky oversaw the Company's vigorous legal defense against talc class action suits and the fallout from the nation's opioid epidemic.
- Related: Opioid Settlement Of $26B Between Drug Companies, States.
- Also See: US House Panel Asks JNJ For Documents Over Talc Liabilities Bankruptcy Plan.
- Price Action: JNJ shares closed 0.78% at $178.57 on Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
